The Pharmacy Times® Pain Management Resource Center is a comprehensive resource for clinical news and expert insights on managing chronic pain with prescription drugs, OTC medications, and physical therapy.
March 28th 2025
Results support a 2020 meta-analysis showing that older adults with chronic pain are nearly twice as likely to develop frailty compared to those without chronic pain.
Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment
1.5 Credits / Cardiology, Neurology, Rare Diseases
View More
Navigating Parkinson Disease: Innovative Approaches to Mitigate OFF Episodes
1.0 Credit / Neurology
View More
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of ...
1.0 Credit / Neurology
View More
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
1.0 Credit / Immunology, Neurology
View More
Exploring Therapeutic Advances for Bipolar Disorder With Mixed Features and Anxious Distress: An Update for Ph...
2.0 Credits / Neurology, Psychiatry
View More
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Prescription Digital Therapeutics in Schizophrenia: A Managed Care Perspective on Advancements
2.0 Credits / Psychiatry
View More
Navigating Innovations: A Managed Care Perspective Addressing the Economic Burden of Schizophrenia
3.0 Credits / Psychiatry
View More
Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Setti...
1.25 Credits / Neurology
View More
Addressing the Unmet Needs in the Management of Myasthenia Gravis: The Role of New and Emerging Therapies
1.5 Credits / Neurology
View More
In-Depth Insights and Application in the Management of Immunoglobulin Therapy
1.0 Credit / Neurology, Immunology
View More
Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies
1.0 Credit / Psychiatry
View More
Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists
1.5 Credit / Pain Management/Opioids
View More
The Role of the Pharmacist Migraine Management
0.5 Credit / Neurology
View More
Overview and Burden of Migraine
0.5 Credit / Neurology
View More
The Evolving Treatment Landscape of Migraine
0.5 Credit / Neurology
View More
Combating Opioid Overdoses: The Impact of Pharmacist-led Counseling and Dispensing of Opioid Reversal Agents
1.0 Credit / Pain Management/Opioids
View More
Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role
1.5 Credits / Pain Management/Opioids
View More
Scientific Community Continues Searching for Answers to Cannabinoid Questions
November 8th 2017State and local marijuana laws continue to evolve toward legalization much faster than the scientific community can collect the data to help society weigh the health, safety, and ethical ramifications of these new laws.
Read More
Biologics, Triple Therapy Effective Option After Failed Initial Methotrexate Treatment
November 7th 2017Patients with rheumatoid arthritis (RA) who took biologics or triple therapy had a longer fail time than patients who took methotrexate oral monotherapy, suggesting that these treatments may be a good follow-up to failed first-line methotrexate treatment.
Read More
Breaking Through Breakthrough Cancer Pain
Breakthrough pain estimates vary, but as many as 50% of patients diagnosed with cancer and chronic pain have pain levels that are not adequately controlled
Read More
Should the Availability of High-Dose Opioids Be Reduced?
September 13th 2017In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses whether the FDA should reduce the availability of high-dose opioids in response to the growing opioid abuse epidemic.
Read More